Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Oscillators Optimized for Fibre Channel Configurations

December 13, 2010 6:01 am | Product Releases | Comments

Fox Electronics, a leading global supplier of frequency control solutions, now offers a new line of Application Specific XpressO oscillators uniquely optimized for Fibre Channel configurations.

Health Net forecasts 2011 earnings per share

December 13, 2010 5:45 am | by The Associated Press | News | Comments

Health insurer Health Net Inc. said Monday it expects a slight rise in commercial enrollment next year and earnings per share of at least $2.05.The Woodland Hills, Calif., insurer said its earnings projection includes severance costs and losses from operations of its Northeast business but it...

AVI BioPharma names board member Garabedian CEO

December 13, 2010 4:45 am | by The Associated Press | News | Comments

AVI BioPharma Inc. on Monday named Chris Garabedian as its CEO and president, effective Jan. 1.Garabedian, 44, replaces interim CEO and president J. David Boyle II, who will stay as chief financial officer and senior vice president. Garabedian has served as vice president of corporate strategy...

Advertisement

Ceapro Announces Share-for-Debt Transaction

December 13, 2010 4:45 am | by The Associated Press | News | Comments

Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Corporation") announced today that it has agreed to issue to each of its directors who have accepted to receive common shares (to be issued at $0.11 per common share) in satisfaction of accrued and unpaid director fees in the aggregate...

Semprus socks away $18M in Series B funds

December 13, 2010 4:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Cambridge-based biomedical company focused on antibacterial coatings Semprus BioSciences Inc. has closed on an $18 million Series B financing round, led by SR One, the corporate venture capital arm of GlaxoSmithKline, and Foundation Medical Partners.

MedShape Solutions, Inc. Secures Investment From IQT to Support U.S. Intelligence Community

December 13, 2010 4:37 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Dec. 13, 2010 /- MedShape Solutions, Inc., the world's leading developer of innovative orthopedic medical devices from shape memory materials, today announced a strategic investment and development agreement from In-Q-Tel (IQT), the strategic investment firm that identifies...

TOPICS:

Ascension Orthopedics Implants PyroTITANâ„¢ in France

December 13, 2010 4:37 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Dec. 13, 2010 /- Ascension Orthopedics, Inc., a market leader in PyroCarbon orthopedic implants, announces the first implantation of the PyroTITAN™ Humeral Resurfacing Implant in France. The PyroTITAN was implanted in a 68-year-old patient suffering from painful...

TOPICS:

First Patient Enrolled in Multi-Center Clinical Trial of the CorMatrix® ECM® for Pericardial Closure to Reduce the Incidence of New Onset Postoperative Atrial Fibrillation

December 13, 2010 4:36 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Dec. 13, 2010 /- CorMatrix Cardiovascular, Inc., an Atlanta-based company dedicated to developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced today that Franciscan...

TOPICS:
Advertisement

Generex Announces Publication of New Positive Generex Oral-lynâ„¢ Data in Peer-Reviewed Journal

December 13, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

WORCESTER, Mass., Dec. 13, 2010 /- Generex Biotechnology Corporation ( www.generex.com ) (OTC Bulletin Board: GNBT ) announced today that the peer-reviewed scientific journal Diabetes, Obesity and Metabolism has published new positive data in respect of Generex Oral-lyn™, the...

TOPICS:

Federal Register: Medical Device User Fee Program; Meetings on Reauthorization; Request for Notification of Patient and Consumer Advocacy Group Intention to Participate

December 13, 2010 4:32 am | by U.S. Food & Drug Administration | News | Comments

The FDA is issuing this notice to request that patient and consumer advocacy groups notify FDA of their intent to participate in periodic consultation meetings on reauthorization of the Medical Device User Fee Amendments of 2007 (MDUFA)...

TOPICS:

Reese Pharmaceutical Company OTC Products: Recall - Mislabeled Guaifenesin Tablets

December 13, 2010 4:31 am | by U.S. Food & Drug Administration | News | Comments

Cold decongestant tablets (containing Acetaminophen, Phenylephrine, and Chlorpheniramine Maleate) were mislabeled as containing only Guaifenesin tablets.

TOPICS:

Thermo Fisher will buy Dionex in $2.1B deal

December 13, 2010 2:47 am | by The Associated Press | News | Comments

Thermo Fisher Scientific Inc. says it will buy laboratory equipment maker Dionex Corp. for $2.1 billion.The Waltham, Massachusetts-based scientific instrument maker says the deal will expand its business in the Asia-Pacific region and help it do more business in industries such as environmental...

Medco buys consulting firm Total Healthcare(2)

December 13, 2010 2:47 am | by The Associated Press | News | Comments

Medco Health Solutions Inc. says it bought Total Healthcare Group of London, a consulting firm that serves clients in the biotechnology industry. Terms were not disclosed.Medco said Monday Total provides payer research, strategic planning, and information on the value of products. Total will...

Medco buys consulting firm Total Healthcare

December 13, 2010 2:46 am | News | Comments

Medco Health Solutions Inc. says it bought Total Healthcare Group of London, a consulting firm that serves clients in the biotechnology industry. Terms were not disclosed.Medco said Monday Total provides payer research, strategic planning, and information on the value of products. Total will...

iLeverage Announces the Successful Sale of the BICO Patent Portfolio for Near-Infrared Non-Invasive Blood Analytes Measurement

December 13, 2010 1:32 am | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO, Dec. 13, 2010 /- iLeverage ( www.ilvrge.com ), a leading patent broker, today announced the successful closing of the Biocontrol patent portfolio sale. The patents were offered to companies that participate in the relevant markets as well as to a number of IP licensing...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading